not the best deal but does avoid dilution at these pricesif the share price isnt significantly higher when the notes convert in 12 months time then its fair to say the company is a dud anyway
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025